Skip to: Content
Skip to: Site Navigation
Skip to: Search
SUNDAY, NOVEMBER 8, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: Ambien

Ambien stories: 3 news summaries

 Money Woes Boost 
 Sales of Sedatives, 
 Antidepressants 

Jump comes despite dive in marketing dollars

Mar 9, 09 3:17 AM CDT
(Newser) - Here's a downer: The sale of antidepressants and sleeping pills have jumped amid the recession, and 31% of Americans asked about their sleeping habits say financial worries are keeping them up at night. The 7% jump in sleep aids comes despite hundreds of millions of fewer dollars spent on their... More »

MORE ABOUT:
antidepressant • marketing • recession • sleeping pills • Ambien • recession depression

8 Worrying Drug Side Effects

FDA-approved medications pass clinical trials, but the real world uncovers more

Mar 7, 08 7:14 PM CST
(Newser) - Despite rigorous testing, some drugs have side effects that only rear their ugly heads when introduced to the general population. Forbes catalogs some of the weirdest:
  1. Anti-smoking drug Chantix can cause insomnia and nightmares.
  2. Diet drug Alli can have unforeseen gastrointestinal side-effects; these can be counteracted by eating
... More »

MORE ABOUT:
FDA • drug safety • list • blood pressure • drug trials • side effects • Ambien • Zolcor • Vasotec • Allegra • Lariam • Chantix • Alli • Mirapex

Prices Jump for Top Drugs

Drug giants collect now against expected future losses

Feb 21, 08 4:45 AM CST
(Newser) - Drug companies have slapped a series of huge price hikes on some prescription drugs ahead of drug patent expirations, the Wall Street Journal reports. GlaxoSmithKline has raised the price of antidepressant Wellbutrin 44.5%, while Sanofi-Aventis hiked Ambien's price 70%. Wholesale prices for the top 50 drugs increased an average... More »

MORE ABOUT:
Barack Obama • Hillary Clinton • John McCain • antidepressant • drug companies • GlaxoSmithKline • Pfizer • health insurance premiums • price increases • health care reform • Centers for Medicare and Medicaid Services • Lipitor • pharmaceutical industry • co-pays • Ambien • Wellbutrin • Adderall XR • Sanofi-Aventis • Shire • patent expiration

3 Stories


from our news partners